These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1505287)

  • 1. Mealtime versus nighttime acid inhibition. A clinical pharmacological study with ranitidine.
    Savarino V; Mela GS; Zentilin P; Vigneri S; Cutela P; Mele R; Di Mario F
    Dig Dis Sci; 1992 Sep; 37(9):1368-72. PubMed ID: 1505287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
    Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
    Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
    J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mansi C; Vassallo A; Franceschi M; Mela MR; Dallorto E; Celle G
    Am J Gastroenterol; 1993 Jul; 88(7):1088-92. PubMed ID: 8317411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing.
    Bianchi Porro G; Parente F; Sangaletti O
    Gut; 1990 Apr; 31(4):397-400. PubMed ID: 2186980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
    Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four-hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily.
    Howden CW; Tsai HH; Reid JL
    Aliment Pharmacol Ther; 1989 Jun; 3(3):253-8. PubMed ID: 2520620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the timing of administration of 300 mg ranitidine on 24-hour gastric pH in patients acute duodenal ulcer.
    Cortot A; Guillemot F; Moreau J; Soule JC; Veyrac M; Alberola B; Pappo M
    Aliment Pharmacol Ther; 1992 Aug; 6(4):487-93. PubMed ID: 1420740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
    Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F
    J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate.
    McIsaac RL; Dixon JS; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1991 Jun; 5(3):227-43. PubMed ID: 1888823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
    Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
    Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Kaufmann D; Mappes A; Heim J; Röhmel J
    Aliment Pharmacol Ther; 1987 Jun; 1(3):217-23. PubMed ID: 2979224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole.
    Robinson M; Rodriguez-Stanley S; Ciociola AA; Filinto J; Zubaidi S; Miner PB; Gardner JD
    Dig Dis Sci; 2002 Feb; 47(2):265-73. PubMed ID: 11855540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer.
    Savarino V; Mela GS; Zentilin P; Bonifacino G; Moretti M; Valle F; Celle G
    Dig Dis Sci; 1989 Jul; 34(7):1043-6. PubMed ID: 2568246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine.
    Savarino V; Mela GS; Zentilin P; Cutela P; Vigneri S; Termini R; Di Mario F; Ferrana M; Malesci A; Belicchi M; Celle G
    Fundam Clin Pharmacol; 1996; 10(3):304-8. PubMed ID: 8836705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective comparison of the effects of placebo, ranitidine and highly selective vagotomy on 24 h ambulatory intragastric pH in patients with duodenal ulcer.
    Rogers MJ; Holmfield JH; Primrose JN; Gledhill T; Johnston D
    Br J Surg; 1988 Oct; 75(10):961-5. PubMed ID: 3219542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose ranitidine: influence of the time of administration on gastric acidity in normal subjects and in patients with duodenal ulcer.
    Coppens JP; Warzee P; Schapira M; Fiasse R; Dive C
    Gastroenterol Clin Biol; 1988; 12(6-7):537-41. PubMed ID: 3417080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large single daily dose of histamine H2 receptor antagonist for duodenal ulcer. How much and when? A clinical pharmacological study.
    Deakin M; Glenny HP; Ramage JK; Mills JG; Burland WL; Williams JG
    Gut; 1987 May; 28(5):566-72. PubMed ID: 3596338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
    Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
    Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.